Skip to main content
. 2020 Mar 19;12:2057–2067. doi: 10.2147/CMAR.S245696

Figure 5.

Figure 5

Oxymatrine inhibits RAS/RAF/MEK/ERK signaling pathway in SW962 and A431 cells. SW962 and A431 cells were treated with or without oxymatrine (3 mg/mL) and salirasib (20 µM) for 48 h. (AD) Protein expression of RAS, RAF, MEK, ERK, p-RAF, p-MEK, p-ERK, C-MYC, and MMP2 as detected by Western blotting. *P<0.05, **P<0.01 compared with 0 mg/mL oxymatrine (control group).